Flyant is a healthcare software engineering and quality assurance company with 16 years of experience delivering regulated software across digital health, medical devices, dental technology, pharma, and life sciences.
We combine software engineering and quality assurance under one delivery model — covering end-to-end product development, healthcare-specialist staff augmentation, test automation, and platform modernisation. Engineering and QA operate as a single function by design, with compliance built into architecture, release processes, and validation from day one.
Our client portfolio spans Abbott, GoodShape, Arklign, GazeHealth, CipherHealth, Therapy Brands, and 20+ healthcare organisations across the US, UK, and EU. 90% of new engagements originate through client referral — a reflection of long-term delivery trust rather than sales volume.
Flyant maintains 250+ in-house engineers, all with prior healthcare delivery experience and 100% at senior or mid-level seniority. Across all engagements: zero failed regulatory audits, zero data breaches, 96% project delivery within budget and timeline.
Certifications: ISO 9001:2015 · ISO/IEC 27001 · ISO/IEC 20000-1 · SOC 2 · ISO 13485 · HIPAA · PCI DSS · FDA 21 CFR Part 11 · ISTQB Foundation · ISTQB Agile Tester · ISTQB Advanced Test Analyst · ISTQB Test Automation Engineer · AWS Certified Security Specialty · CKA · SAFe / Scrum Alliance
Compliance coverage includes HIPAA, FDA 21 CFR Part 11, IEC 62304, HL7, FHIR, DICOM, SOC 2, GxP, and GDPR.
Core delivery areas: EHR/EMR systems, telehealth platforms, remote patient monitoring, SaMD, clinical data infrastructure, and enterprise wellness platforms.
Flyant is a healthcare software engineering and quality assurance company with 16 years of experience delivering regulated software across digital health, medical devices, dental technology, pharma, and life sciences.
We combine software engineering and quality assurance under one delivery model — covering end-to-end product development, healthcare-specialist staff augmentation, test automation, and platform modernisation. Engineering and QA operate as a single function by design, with compliance built into architecture, release processes, and validation from day one.
Our client portfolio spans Abbott, GoodShape, Arklign, GazeHealth, CipherHealth, Therapy Brands, and 20+ healthcare organisations across the US, UK, and EU. 90% of new engagements originate through client referral — a reflection of long-term delivery trust rather than sales volume.
Flyant maintains 250+ in-house engineers, all with prior healthcare delivery experience and 100% at senior or mid-level seniority. Across all engagements: zero failed regulatory audits, zero data breaches, 96% project delivery within budget and timeline.
Certifications: ISO 9001:2015 · ISO/IEC 27001 · ISO/IEC 20000-1 · SOC 2 · ISO 13485 · HIPAA · PCI DSS · FDA 21 CFR Part 11 · ISTQB Foundation · ISTQB Agile Tester · ISTQB Advanced Test Analyst · ISTQB Test Automation Engineer · AWS Certified Security Specialty · CKA · SAFe / Scrum Alliance
Compliance coverage includes HIPAA, FDA 21 CFR Part 11, IEC 62304, HL7, FHIR, DICOM, SOC 2, GxP, and GDPR.
Core delivery areas: EHR/EMR systems, telehealth platforms, remote patient monitoring, SaMD, clinical data infrastructure, and enterprise wellness platforms.
Location and contacts
Major clients
Processes and approach
How do you gather and validate client requirements?
We open every engagement with a structured discovery phase — mapping clinical workflows, regulatory scope, and integration dependencies before any delivery decisions are made.
Requirements are validated with clinical and technical stakeholders, cross-referenced against applicable compliance frameworks from day one. Ambiguities are resolved in writing before development begins.
Throughout delivery, requirements traceability is maintained from specification through to test evidence — ensuring what was agreed is what gets built and audited.
How do you ensure alignment with client goals and business strategy?
Before delivery begins, we map client goals, regulatory constraints, and business priorities into a shared framework — so engineering decisions are made in context, not in isolation.
Throughout the engagement, weekly delivery updates, monthly quality scorecards, and quarterly leadership reviews keep strategic alignment visible and maintained.
Clients retain full ownership of product direction. We own execution, quality, and release readiness.
Which software development methodologies do you use (e.g., Agile, Waterfall, Scrum)?
We work primarily within Agile frameworks — Scrum and SAFe — with two-week delivery cycles, continuous integration, and sprint-level release readiness assessment. Methodology selection is calibrated to engagement type and regulatory context.
For scope-defined or compliance-heavy deliverables, we apply structured phases with formal acceptance criteria, traceability documentation, and validation gates — elements that Agile alone does not enforce by default.
In practice, most engagements combine iterative delivery with the documentation discipline that regulated healthcare environments require.
How do you keep clients and stakeholders updated on project progress?
Reporting is structured across three cadences: weekly delivery updates covering sprint progress, blockers, and upcoming milestones; monthly quality scorecards tracking defect rates, coverage, and release readiness; and quarterly leadership reviews addressing strategic alignment, risk, and delivery trajectory.
All reporting is written, timestamped, and retained — providing an auditable record of decisions and status throughout the engagement.
Critical issues are escalated immediately, outside the standard cadence. Clients are never informed of a problem for the first time at a review.
How frequently do you hold check-in meetings or status updates?
Check-in cadence is set at engagement start and adjusted to client preference. The default structure: daily standups within the delivery team, weekly client-facing status calls covering progress, blockers, and next steps, and monthly reviews focused on quality metrics and delivery health.
Quarterly leadership sessions address strategic alignment and long-term trajectory.
Outside the scheduled cadence, critical issues are escalated immediately — by direct communication, not queued for the next meeting.
What quality assurance practices do you follow?
Quality assurance is embedded from day one — not applied as a final checkpoint. Engineering and QA operate under a single contract, with test strategy defined at architecture stage and validation evidence accrued continuously.
We apply risk-based testing aligned to regulatory impact, automated regression frameworks, and defined release readiness criteria signed off every cycle.
Full traceability from requirements to test evidence. Zero failed regulatory audits across all products under our quality ownership.
How do you identify and manage project risks?
Risk identification begins in discovery — before architecture is finalised or development starts. Clinical workflows, regulatory scope, integration dependencies, and delivery constraints are mapped and prioritised by impact, not assumption.
Identified risks are documented, owned, and tracked throughout delivery. Each sprint includes a risk review; material changes to scope, compliance posture, or technical dependencies trigger immediate reassessment.
Clients are informed of emerging risks as they surface — not at the point where options have already narrowed.
What kind of support or maintenance do you offer after delivery?
Post-delivery support is structured into the engagement from the outset — not treated as an optional add-on. At launch, we provide production monitoring, incident response, and defect remediation under defined SLAs.
Longer-term, we offer continuous development under retained delivery models, platform modernisation as systems evolve, and ongoing quality engineering to maintain release stability and audit readiness.
Where clients choose to internalise operations, we provide a documented handover — a working system with full traceability, not a dependency on our continued involvement.